Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.24.3
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Net revenue $ 28,546 $ 29,280 $ 82,598 $ 88,643
Direct operating costs 15,420 18,260 45,839 53,843
Selling and marketing 1,375 2,337 4,809 7,529
General and administrative 4,378 5,482 12,127 16,518
Research and development 800 1,260 2,768 3,523
Depreciation and amortization 3,241 3,903 10,885 10,282
Loss on lease terminations, unoccupied lease charges and restructuring costs 67 8 505 430
Total operating expenses 25,281 31,250 76,933 92,125
OPERATING INCOME (LOSS) 3,265 (1,970) 5,665 (3,482)
Healthcare IT [Member]        
Segment Reporting Information [Line Items]        
Net revenue 24,302 25,592 71,603 78,531
Direct operating costs 12,445 15,369 37,699 46,003
Selling and marketing 1,368 2,329 4,785 7,503
General and administrative 2,321 2,719 6,923 8,466
Research and development 800 1,260 2,768 3,523
Depreciation and amortization 3,159 3,814 10,638 10,013
Loss on lease terminations, unoccupied lease charges and restructuring costs 67 8 505 430
Total operating expenses 20,160 25,499 63,318 75,938
OPERATING INCOME (LOSS) 4,142 93 8,285 2,593
Medical Practice Management [Member]        
Segment Reporting Information [Line Items]        
Net revenue 4,244 3,688 10,995 10,112
Direct operating costs 2,975 2,891 8,140 7,840
Selling and marketing 7 8 24 26
General and administrative 481 466 1,392 1,362
Research and development
Depreciation and amortization 82 89 247 269
Loss on lease terminations, unoccupied lease charges and restructuring costs
Total operating expenses 3,545 3,454 9,803 9,497
OPERATING INCOME (LOSS) 699 234 1,192 615
Unallocated Corporate Expenses [Member]        
Segment Reporting Information [Line Items]        
Net revenue
Direct operating costs
Selling and marketing
General and administrative 1,576 2,297 3,812 6,690
Research and development
Depreciation and amortization
Loss on lease terminations, unoccupied lease charges and restructuring costs
Total operating expenses 1,576 2,297 3,812 6,690
OPERATING INCOME (LOSS) $ (1,576) $ (2,297) $ (3,812) $ (6,690)